These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39355871)

  • 1. Sinusoidal communication in chronic liver disease.
    Gibert-Ramos A; Andrés-Rozas M; Pastó R; Alfaro-Retamero P; Guixé-Muntet S; Gracia-Sancho J
    Clin Mol Hepatol; 2024 Oct; ():. PubMed ID: 39355871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer.
    Gibert-Ramos A; Sanfeliu-Redondo D; Aristu-Zabalza P; Martínez-Alcocer A; Gracia-Sancho J; Guixé-Muntet S; Fernández-Iglesias A
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging and Chronic Liver Disease.
    Maeso-Díaz R; Gracia-Sancho J
    Semin Liver Dis; 2020 Nov; 40(4):373-384. PubMed ID: 33764489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiocrine signaling in sinusoidal homeostasis and liver diseases.
    Gao J; Lan T; Kostallari E; Guo Y; Lai E; Guillot A; Ding B; Tacke F; Tang C; Shah VH
    J Hepatol; 2024 Sep; 81(3):543-561. PubMed ID: 38763358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Face Chronic Liver Disease: The Sinusoidal Perspective.
    Fernández-Iglesias A; Gracia-Sancho J
    Front Med (Lausanne); 2017; 4():7. PubMed ID: 28239607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
    Iwakiri Y; Shah V; Rockey DC
    J Hepatol; 2014 Oct; 61(4):912-24. PubMed ID: 24911462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment.
    Mishra F; Yuan Y; Yang JJ; Li B; Chan P; Liu Z
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.
    Baffy G
    Dig Dis Sci; 2018 Mar; 63(3):563-576. PubMed ID: 29368124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinusoidal communication in liver fibrosis and regeneration.
    Marrone G; Shah VH; Gracia-Sancho J
    J Hepatol; 2016 Sep; 65(3):608-17. PubMed ID: 27151183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte-Mediated Paracrine Mechanism.
    Gracia-Sancho J; Manicardi N; Ortega-Ribera M; Maeso-Díaz R; Guixé-Muntet S; Fernández-Iglesias A; Hide D; García-Calderó H; Boyer-Díaz Z; Contreras PC; Spada A; Bosch J
    Hepatol Commun; 2019 Jul; 3(7):987-1000. PubMed ID: 31304452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic microcirculation and mechanisms of portal hypertension.
    Gracia-Sancho J; Marrone G; Fernández-Iglesias A
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):221-234. PubMed ID: 30568278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired antibacterial response of liver sinusoidal Vγ9
    Rha MS; Han JW; Koh JY; Lee HS; Kim JH; Cho K; Kim SI; Kim MS; Lee JG; Park SH; Joo DJ; Park JY; Shin EC
    Gut; 2022 Mar; 71(3):605-615. PubMed ID: 33472894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment.
    Turaga RC; Satyanarayana G; Sharma M; Yang JJ; Wang S; Liu C; Li S; Yang H; Grossniklaus H; Farris AB; Gracia-Sancho J; Liu ZR
    Commun Biol; 2021 Sep; 4(1):1087. PubMed ID: 34531529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis.
    Garbuzenko DV; Arefyev NO; Belov DV
    World J Hepatol; 2016 Jun; 8(16):665-72. PubMed ID: 27326313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights.
    Greuter T; Shah VH
    J Gastroenterol; 2016 Jun; 51(6):511-9. PubMed ID: 26939970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?
    Thabut D; Shah V
    J Hepatol; 2010 Nov; 53(5):976-80. PubMed ID: 20800926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
    Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
    J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy.
    Iwakiri Y; Trebicka J
    JHEP Rep; 2021 Aug; 3(4):100316. PubMed ID: 34337369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.